Terazosin Hydrochloride

CHEMBL3989562 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

459.9 g/mol

LogP

—

Phase

4

A hydrochloride salt form of terazosin with the same therapeutic properties. This medication relaxes the muscles in blood vessel walls and the prostate, and is used to treat high blood pressure and the urinary symptoms of an enlarged prostate (BPH).

Moleküler Ağırlık

459,9000 g/mol

TPSA

105,00 Å²

Terapötik Alanlar

Benign Prostatic Hyperplasia Cardiovascular Disease Parkinson's Disease Stroke Type 2 Diabetes Hypertension Atrial Fibrillation

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O.O

InChI

InChI=1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2

Molecular Formula

C19H30ClN5O6

HBD / HBA

4 / 10

Döndürülebilir Bağlar

4

Ağır Atomlar

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A hydrochloride salt form of terazosin with the same therapeutic properties. This medication relaxes the muscles in blood vessel walls and the prostate, and is used to treat high blood pressure and the urinary symptoms of an enlarged prostate (BPH).

Yes, Terazosin Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989562. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 63016. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Terazosin Hydrochloride PillFYI'da

Yapı

Hızlı Veriler

Formül: C19H30ClN5O6
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.